Cardiac resynchronization therapy with or without anatomical reverse remodeling does not affect defibrillation...

Area of Science:

• Cardiology
• Electrophysiology
• Medical Devices

Background:

• Cardiac resynchronization therapy (CRT) shows beneficial reverse-remodeling effects in heart failure patients.
• Investigating CRT's impact on defibrillation threshold (DFT) is crucial for device efficacy.
• Left ventricular remodeling is a key indicator of CRT success.

Purpose of the Study:

• To evaluate the effect of CRT, with or without left ventricular reverse anatomical remodeling, on DFT levels.
• To assess DFT in patients with systolic heart failure receiving CRT-defibrillator (CRT-D) devices.
• To determine if reverse anatomical remodeling influences DFT in CRT-D recipients.

Main Methods:

• Prospective study of 29 patients (Class II-IV systolic heart failure) undergoing CRT-D implantation.
• Baseline and 6-month follow-up DFT testing performed.
• Reverse anatomical remodeling defined as ≥15% reduction in left ventricular end-systolic volume.

Main Results:

• Baseline average DFT was 8.8±5.9 J; left ventricular end-diastolic volume predicted baseline DFT.
• All patients achieved a safety margin of at least 10 J at baseline.
• At 6 months, average DFT was 9.2±6.9 J; 3.4% of patients had DFT < 10 J.
• Reverse anatomical remodeling occurred in 48% of patients but did not affect DFT levels.

Conclusions:

• CRT-D in heart failure patients resulted in a baseline average DFT ≤10 J.
• CRT-D, irrespective of reverse anatomical remodeling, did not significantly alter DFT at 6 months.
• High DFT levels post-CRT-D are uncommon, suggesting device reliability.